| 1 | Glucagonoma | 52.3% |
| 2 | Vipoma | 45.1% |
| 3 | Carcinoma, Pancreatic Ductal | 37.2% |
| 4 | Peritoneal Neoplasms | 24.5% |
| 5 | insulinoma | 24.2% |
| 6 | Parathyroid Neoplasms | 21.2% |
| 7 | Thyroid Neoplasm | 21.2% |
| 8 | Thyroid carcinoma | 21.2% |
| 9 | Gastrointestinal Neoplasms | 20.9% |
| 10 | Liver neoplasms | 20.9% |
| 11 | Multiple Endocrine Neoplasia | 20.7% |
| 12 | Carcinoma, Lobular | 17.4% |
| 13 | Adrenal Gland Neoplasms | 17.3% |
| 14 | Esophageal Neoplasms | 17% |
| 15 | Testicular Neoplasms | 15.1% |
| 16 | Hepatocellular Adenoma | 14.9% |
| 17 | Cystadenocarcinoma | 14.8% |
| 18 | Mucoepidermoid Carcinoma | 14.8% |
| 19 | Abdominal Neoplasms | 14.5% |
| 20 | Head and Neck Neoplasms | 14.5% |
| 21 | Soft Tissue Neoplasms | 14.5% |
| 22 | Thoracic Neoplasms | 14.5% |
| 23 | Carcinoma, Ehrlich Tumor | 14.2% |
| 24 | Carcinoma, Lewis Lung | 14.2% |
| 25 | Liver Neoplasms, Experimental | 14.1% |
| 26 | Pancreatic Cyst | 13.6% |
| 27 | Basal cell carcinoma | 13.4% |
| 28 | Carcinoma, Papillary | 13.4% |
| 29 | Squamous cell carcinoma | 13.4% |
| 30 | Carcinoma, Basal Cell | 13.4% |
| 31 | Adrenocortical carcinoma | 13.4% |
| 32 | ovarian neoplasm | 13.4% |
| 33 | Carcinoma, Ovarian Epithelial | 13.1% |
| 34 | Bile Duct Neoplasms | 13% |
| 35 | gallbladder neoplasm | 13% |
| 36 | Intestinal Neoplasms | 13% |
| 37 | Stomach Neoplasms | 13% |
| 38 | Eye Neoplasms | 13% |
| 39 | Nervous System Neoplasms | 13% |
| 40 | Bone neoplasms | 12.8% |
| 41 | Skin Neoplasms | 12.8% |
| 42 | Hematologic Neoplasms | 12.8% |
| 43 | Splenic Neoplasms | 12.7% |
| 44 | Choriocarcinoma | 12.6% |
| 45 | Thyroid Nodule | 12.4% |
| 46 | Neoplasms, Neuroepithelial | 12.2% |
| 47 | Gliomatosis cerebri | 12.2% |
| 48 | Carcinoid Tumor | 12% |
| 49 | Hamartoma | 11.9% |
| 50 | Neoplasms, Hormone-Dependent | 11.9% |
| 51 | Neoplasms, Multiple Primary | 11.9% |
| 52 | Paraneoplastic Syndromes | 11.9% |
| 53 | Precancerous Conditions | 11.9% |
| 54 | Neoplasms, Second Primary | 11.9% |
| 55 | Pituitary Adenoma | 11.9% |
| 56 | Pituitary Neoplasms | 11.9% |
| 57 | Prolactinoma | 11.7% |
| 58 | Growth Hormone-Secreting Pituitary Adenoma | 11.7% |
| 59 | Multiple Endocrine Neoplasia Type 1 | 11.7% |
| 60 | Acanthoma | 11.7% |
| 61 | Adenoid Cystic Carcinoma | 11.5% |
| 62 | Adenocarcinoma, Clear Cell | 11.5% |
| 63 | Cholangiocarcinoma | 11.5% |
| 64 | Digestive System Neoplasms | 11.2% |
| 65 | Paraneoplastic Encephalomyelitis | 11.1% |
| 66 | Zollinger-Ellison syndrome | 11.1% |
| 67 | Mammary Neoplasms, Experimental | 11% |
| 68 | Pancreatic Fistula | 10.9% |
| 69 | Cyst | 10.5% |
| 70 | Neoplastic Processes | 10.5% |
| 71 | Neoplastic Syndromes, Hereditary | 10.5% |
| 72 | Pregnancy Complications, Neoplastic | 10.5% |
| 73 | Neoplasms, Experimental | 10.4% |
| 74 | Adenomatous Polyposis Coli | 10.2% |
| 75 | leukemia | 10.1% |
| 76 | Neoplasms, Germ Cell and Embryonal | 10.1% |
| 77 | Germ Cell Cancer | 10.1% |
| 78 | Carcinoma in Situ | 9.9% |
| 79 | Carcinoma, Transitional Cell | 9.9% |
| 80 | Carcinoma, Large Cell | 9.9% |
| 81 | Carcinoma, Small Cell | 9.9% |
| 82 | Meningioma | 9.8% |
| 83 | Choledochal Cyst | 9.6% |
| 84 | Adenoma | 9.5% |
| 85 | Neuroectodermal Tumors | 9.5% |
| 86 | Cystadenoma | 9.4% |
| 87 | Mesothelioma | 9.4% |
| 88 | Neoplasms, Radiation-Induced | 9.3% |
| 89 | Colorectal Neoplasms | 9.3% |
| 90 | Pancreatic Insufficiency | 9.3% |
| 91 | Pancreatitis | 9.3% |
| 92 | granulosa cell tumor | 9.1% |
| 93 | Trophoblastic Neoplasms | 9.1% |
| 94 | Leukemia, Experimental | 9% |
| 95 | Tracheal Neoplasms | 9% |
| 96 | Cecal Neoplasms | 9% |
| 97 | Duodenal Neoplasms | 9% |
| 98 | Pancreatic Neoplasm | 8.9% |
| 99 | Gastrointestinal Stromal Tumors | 8.9% |
| 100 | Histiocytic Disorders, Malignant | 8.9% |
| 101 | Tuberous Sclerosis | 8.8% |
| 102 | Carcinoma 256, Walker | 8.7% |
| 103 | Carcinoma, Endometrioid | 8.6% |
| 104 | Renal Cell Carcinoma | 8.5% |
| 105 | Papillary Renal Cell Carcinoma | 8.5% |
| 106 | Biliary Tract Diseases | 8.5% |
| 107 | Gastrointestinal Diseases | 8.5% |
| 108 | Liver diseases | 8.5% |
| 109 | Leukemia, Radiation-Induced | 8.2% |
| 110 | Bowen's Disease | 8.2% |
| 111 | Malignant Carcinoid Syndrome | 8.1% |
| 112 | Dermoid Cyst | 8.1% |
| 113 | Retroperitoneal Neoplasms | 7.9% |
| 114 | Basal Cell Nevus Syndrome | 7.9% |
| 115 | Thymoma | 7.9% |
| 116 | Lymphoma | 7.9% |
| 117 | Barrett Esophagus | 7.8% |
| 118 | Pancreatic Pseudocyst | 7.8% |
| 119 | Klatskin Tumor | 7.7% |
| 120 | Melanoma, Experimental | 7.6% |
| 121 | Retinoblastoma | 7.6% |
| 122 | Composite Lymphoma | 7.6% |
| 123 | Carcinosarcoma | 7.4% |
| 124 | Hemangiosarcoma | 7.4% |
| 125 | lymphangiosarcoma | 7.4% |
| 126 | Endocrine Gland Neoplasms | 7.4% |
| 127 | Nephroblastoma | 7.3% |
| 128 | melanoma | 7.2% |
| 129 | Sarcoma, Experimental | 7.2% |
| 130 | Adenoma, Acidophil | 7.2% |
| 131 | Ganglioneuroma | 7.2% |
| 132 | Glioma | 7.2% |
| 133 | Malignant Glioma | 7.2% |
| 134 | Mouth Neoplasms | 7% |
| 135 | Central Nervous System Neoplasms | 7% |
| 136 | Vascular Neoplasms | 7% |
| 137 | Thymus Neoplasms | 7% |
| 138 | Medulloblastoma | 7% |
| 139 | Genital Neoplasms, Female | 7% |
| 140 | Breast Neoplasms, Male | 6.9% |
| 141 | Triple Negative Breast Neoplasms | 6.9% |
| 142 | Leydig Cell Tumor | 6.7% |
| 143 | Cystic Fibrosis | 6.7% |
| 144 | Appendiceal Neoplasms | 6.7% |
| 145 | Colonic Neoplasms | 6.7% |
| 146 | Rectal Neoplasms | 6.7% |
| 147 | Leukemia, Plasma Cell | 6.6% |
| 148 | Nasopharyngeal carcinoma | 6.6% |
| 149 | Congenital Hyperinsulinism | 6.5% |
| 150 | Genital Neoplasms, Male | 6.3% |
| 151 | Uveal Neoplasms | 6.3% |
| 152 | Urologic Neoplasms | 6.3% |
| 153 | Sebaceous Gland Neoplasms | 6.2% |
| 154 | Spinal Neoplasms | 6.2% |
| 155 | Bone Marrow Neoplasms | 6.2% |
| 156 | Erythroplasia | 6.1% |
| 157 | Follicular cyst | 6.1% |
| 158 | Mucocele | 6.1% |
| 159 | Pilonidal Cyst | 6.1% |
| 160 | Thyroglossal Cyst | 6.1% |
| 161 | Synovial Cyst | 6.1% |
| 162 | Aberrant Crypt Foci | 6.1% |
| 163 | Cervical Intraepithelial Neoplasia | 6% |
| 164 | Nelson Syndrome | 6% |
| 165 | Adenofibroma | 5.9% |
| 166 | Fibroadenoma | 5.9% |
| 167 | Corpus Luteum Cyst | 5.9% |
| 168 | Ovarian Cysts | 5.9% |
| 169 | Anus Neoplasms | 5.9% |
| 170 | Sigmoid Neoplasms | 5.9% |
| 171 | Mesenteric vascular insufficiency | 5.8% |
| 172 | Esophageal Atresia | 5.8% |
| 173 | Intestinal Atresia | 5.8% |
| 174 | Mesenteric Vascular Occlusion | 5.8% |
| 175 | Intestinal Fistula | 5.8% |
| 176 | Enterocutaneous Fistula | 5.8% |
| 177 | Leukoplakia, Oral | 5.7% |
| 178 | Carcinoid Heart Disease | 5.7% |
| 179 | Paraneoplastic Cerebellar Degeneration | 5.6% |
| 180 | Lymphomatoid Granulomatosis | 5.6% |
| 181 | Leukemia L1210 | 5.6% |
| 182 | Leukemia P388 | 5.6% |
| 183 | Acoustic Neuroma | 5.6% |
| 184 | Peutz-Jeghers Syndrome | 5.6% |
| 185 | Pancreatitis, Chronic | 5.5% |
| 186 | Leukoplakia | 5.4% |
| 187 | Lymphocele | 5.4% |
| 188 | Chondrosarcoma | 5.4% |
| 189 | Craniopharyngioma | 5.4% |
| 190 | leiomyosarcoma | 5.4% |
| 191 | liposarcoma | 5.4% |
| 192 | synovial sarcoma | 5.4% |
| 193 | Neuroectodermal Tumor, Melanotic | 5.4% |
| 194 | Angiomyolipoma | 5.4% |
| 195 | Clear Cell Sarcoma of Soft Tissue | 5.4% |
| 196 | Alveolar Soft Part Sarcoma | 5.4% |
| 197 | Neuroendocrine Tumors | 5.4% |
| 198 | Sarcoma, Myeloid | 5.4% |
| 199 | Ameloblastoma | 5.4% |
| 200 | Angiokeratoma | 5.4% |
| 201 | Chordoma | 5.4% |
| 202 | Hemangioma | 5.4% |
| 203 | hemangiopericytoma | 5.4% |
| 204 | Lymphangioma | 5.4% |
| 205 | Mesenchymoma | 5.4% |
| 206 | Nevus | 5.4% |
| 207 | Teratoma | 5.4% |
| 208 | Hepatoblastoma | 5.4% |
| 209 | Mixed Tumor, Mullerian | 5.4% |
| 210 | Germinoma | 5.4% |
| 211 | Teratocarcinoma | 5.4% |
| 212 | Angiofibroma | 5.4% |
| 213 | Sarcoma | 5.4% |
| 214 | Breast Cyst | 5.4% |
| 215 | Actinic keratosis | 5.4% |
| 216 | Mediastinal Cyst | 5.4% |
| 217 | Neoplasm Invasiveness | 5.4% |
| 218 | Neoplasm Metastasis | 5.4% |
| 219 | Neoplasm Recurrence, Local | 5.4% |
| 220 | Parovarian Cyst | 5.4% |
| 221 | Pericardial Cyst | 5.4% |
| 222 | Thymic Cyst | 5.4% |
| 223 | Carcinogenesis | 5.4% |
| 224 | Myxoid cyst | 5.4% |
| 225 | Metastasis | 5.4% |
| 226 | Biliary cirrhosis | 5.4% |
| 227 | Papilloma | 5.4% |
| 228 | Pseudomyxoma Peritonei | 5.4% |
| 229 | Papillomatosis | 5.4% |
| 230 | Adenomatosis, Pulmonary | 5.4% |
| 231 | Adenomatous Polyps | 5.4% |
| 232 | Nose Neoplasms | 5.2% |
| 233 | Limbic Encephalitis | 5.1% |
| 234 | Endometrial Stromal Sarcoma | 5.1% |
| 235 | Optic Nerve Glioma | 5% |
| 236 | Mesoblastic Nephroma | 4.9% |
| 237 | Proctocolitis | 4.9% |
| 238 | Dysentery | 4.8% |
| 239 | Enteritis | 4.8% |
| 240 | Enterocolitis | 4.8% |
| 241 | Esophageal and Gastric Varices | 4.8% |
| 242 | Esophagitis | 4.8% |
| 243 | Gastritis | 4.8% |
| 244 | Inflammatory Bowel Diseases | 4.8% |
| 245 | Cholecystolithiasis | 4.8% |
| 246 | Pancreatitis, Alcoholic | 4.8% |
| 247 | Lambert-Eaton Myasthenic Syndrome | 4.8% |
| 248 | Plasmacytoma | 4.7% |
| 249 | Malignant histiocytosis | 4.7% |
| 250 | Histiocytic sarcoma | 4.7% |
| 251 | Astrocytoma | 4.7% |
| 252 | Ependymoma | 4.7% |
| 253 | oligodendroglioma | 4.7% |
| 254 | Ganglioglioma | 4.7% |
| 255 | gliosarcoma | 4.7% |
| 256 | Anaplastic astrocytoma | 4.7% |
| 257 | Anaplastic Oligodendroglioma | 4.7% |
| 258 | Bile Duct Diseases | 4.6% |
| 259 | Cholelithiasis | 4.6% |
| 260 | Chylous Ascites | 4.6% |
| 261 | Esophageal Diseases | 4.6% |
| 262 | Fatty Liver | 4.6% |
| 263 | Gastroenteritis | 4.6% |
| 264 | Hepatitis | 4.6% |
| 265 | Portal Hypertension | 4.6% |
| 266 | Intestinal Diseases | 4.6% |
| 267 | Liver Cirrhosis | 4.6% |
| 268 | Pneumoperitoneum | 4.6% |
| 269 | Stomach Diseases | 4.6% |
| 270 | Focal Nodular Hyperplasia | 4.6% |
| 271 | Hepatic Insufficiency | 4.6% |
| 272 | Steatohepatitis | 4.6% |
| 273 | Sarcoma 180 | 4.6% |
| 274 | Palatal Neoplasms | 4.6% |
| 275 | Neurilemmoma | 4.5% |
| 276 | Hutchinson's Melanotic Freckle | 4.5% |
| 277 | Melanoma, Amelanotic | 4.5% |
| 278 | Rectal Fistula | 4.5% |
| 279 | Anal Fistula | 4.5% |
| 280 | Opsoclonus-Myoclonus Syndrome | 4.4% |
| 281 | Fibrosarcoma | 4.4% |
| 282 | Osteosarcoma | 4.4% |
| 283 | Lymphangioleiomyomatosis | 4.3% |
| 284 | Fatty Liver, Alcoholic | 4.3% |
| 285 | Hepatitis, Alcoholic | 4.3% |
| 286 | Liver Cirrhosis, Alcoholic | 4.3% |
| 287 | Duodenitis | 4.3% |
| 288 | Ileitis | 4.3% |
| 289 | Erosive Duodenitis | 4.3% |
| 290 | Adrenal Gland Diseases | 4.3% |
| 291 | Gonadal Disorders | 4.3% |
| 292 | Pancreatic Diseases | 4.3% |
| 293 | Parathyroid Diseases | 4.3% |
| 294 | Thyroid Diseases | 4.3% |
| 295 | Hodgkin Disease | 4.2% |
| 296 | Lymphoma, Non-Hodgkin | 4.2% |
| 297 | Neoplasms, Glandular and Epithelial | 4.2% |
| 298 | Liver Diseases, Parasitic | 4.2% |
| 299 | Meningeal Neoplasms | 4.1% |
| 300 | Hepatic Veno-Occlusive Disease | 4.1% |
| 301 | Peliosis Hepatis | 4.1% |
| 302 | Hepatopulmonary Syndrome | 4.1% |
| 303 | Anus, Imperforate | 4.1% |
| 304 | Gastrointestinal Hemorrhage | 4.1% |
| 305 | Hemoperitoneum | 4.1% |
| 306 | Hepatomegaly | 4.1% |
| 307 | Mesenteric Panniculitis | 4.1% |
| 308 | Panniculitis, Peritoneal | 4.1% |
| 309 | Peritonitis | 4.1% |
| 310 | Peritoneal Fibrosis | 4.1% |
| 311 | Encapsulating Peritoneal Sclerosis | 4.1% |
| 312 | Anorectal Malformations | 4.1% |
| 313 | Myelitis, Transverse | 4.1% |
| 314 | Biliary Fistula | 4.1% |
| 315 | Gastric Fistula | 4.1% |
| 316 | Hepatic Vein Thrombosis | 4% |
| 317 | Liver Abscess | 4% |
| 318 | Budd-Chiari Syndrome | 4% |
| 319 | Tuberculosis, Gastrointestinal | 4% |
| 320 | Colitis | 4% |
| 321 | Duodenogastric Reflux | 4% |
| 322 | Peptic Ulcer | 4% |
| 323 | Proctitis | 4% |
| 324 | Choledocholithiasis | 4% |
| 325 | Malignant Fibrous Histiocytoma | 3.9% |
| 326 | Nesidioblastosis | 3.9% |
| 327 | Primary amyloidosis | 3.8% |
| 328 | Bone Diseases, Endocrine | 3.8% |
| 329 | Ear Neoplasms | 3.7% |
| 330 | Eyelid Neoplasms | 3.7% |
| 331 | Lung Neoplasms | 3.7% |
| 332 | Pleural Neoplasms | 3.7% |
| 333 | Denys-Drash Syndrome | 3.7% |
| 334 | Diabetes Mellitus | 3.7% |
| 335 | Pituitary Diseases | 3.7% |
| 336 | Chemical and Drug Induced Liver Injury | 3.7% |
| 337 | Brain Neoplasms | 3.7% |
| 338 | Salivary Gland Neoplasms | 3.7% |
| 339 | Spinal Cord Neoplasms | 3.7% |
| 340 | Tongue Neoplasms | 3.7% |
| 341 | Uterine Neoplasms | 3.7% |
| 342 | Vaginal Neoplasms | 3.7% |
| 343 | Vulvar Neoplasms | 3.7% |
| 344 | Uterine Cancer | 3.7% |
| 345 | Fallopian Tube Neoplasms | 3.6% |
| 346 | Hepatorenal Syndrome | 3.6% |
| 347 | Appendicitis | 3.6% |
| 348 | Liver Abscess, Amebic | 3.6% |
| 349 | Gastrinoma | 3.5% |
| 350 | Glioblastoma | 3.4% |
| 351 | Neuroblastoma | 3.4% |
| 352 | Glioblastoma Multiforme | 3.4% |
| 353 | Paraganglioma | 3.4% |
| 354 | Rhabdomyosarcoma | 3.4% |
| 355 | Giant Cell Tumor of Bone | 3.4% |
| 356 | Pharyngeal Neoplasms | 3.4% |
| 357 | Central Nervous System Cysts | 3.3% |
| 358 | Dwarfism | 3.3% |
| 359 | Neurofibrosarcoma | 3.3% |
| 360 | Penile Neoplasms | 3.3% |
| 361 | Prostatic Neoplasms | 3.3% |
| 362 | Polycystic Ovary Syndrome | 3.3% |
| 363 | Polycythemia Vera | 3.3% |
| 364 | Porphyrias, Hepatic | 3.3% |
| 365 | Crohn Disease | 3.2% |
| 366 | Duodenal Obstruction | 3.2% |
| 367 | Enterocolitis, Neutropenic | 3.2% |
| 368 | Necrotizing Enterocolitis | 3.2% |
| 369 | Pouchitis | 3.2% |
| 370 | Waldenstrom Macroglobulinemia | 3.2% |
| 371 | Multiple Myeloma | 3.2% |
| 372 | Xeroderma Pigmentosum | 3.1% |
| 373 | Laryngeal neoplasm | 3.1% |
| 374 | Phyllodes Tumor | 3.1% |
| 375 | Dysgerminoma | 3.1% |
| 376 | Hemangioendothelioma | 3.1% |
| 377 | Lipoma | 3.1% |
| 378 | Myoma | 3.1% |
| 379 | Myxoma | 3.1% |
| 380 | Neuroma | 3.1% |
| 381 | Seminoma | 3.1% |
| 382 | Angiolipoma | 3.1% |
| 383 | Myelolipoma | 3.1% |
| 384 | Neoplasms, Bone Tissue | 3.1% |
| 385 | Neoplasms, Fibrous Tissue | 3.1% |
| 386 | Smooth Muscle Tumor | 3.1% |
| 387 | Desmoplastic Small Round Cell Tumor | 3.1% |
| 388 | Chondroma | 3.1% |
| 389 | Enchondroma | 3.1% |
| 390 | Hydatidiform Mole | 3% |
| 391 | Bladder Neoplasm | 3% |
| 392 | Kidney Neoplasm | 3% |
| 393 | Ureteral Neoplasms | 3% |
| 394 | Urethral Neoplasms | 3% |
| 395 | Lymphatic Metastasis | 2.9% |
| 396 | Neoplasms, Unknown Primary | 2.9% |
| 397 | Leukemic Infiltration | 2.9% |
| 398 | Neoplasm Micrometastasis | 2.9% |
| 399 | Dermatofibrosarcoma | 2.9% |
| 400 | Dermatofibrosarcoma Protuberans | 2.9% |
| 401 | Enterocolitis, Pseudomembranous | 2.8% |
| 402 | pseudomembranous colitis | 2.8% |
| 403 | Dysentery, Bacillary | 2.8% |
| 404 | Ganglioneuroblastoma | 2.8% |
| 405 | Duodenal Ulcer | 2.8% |
| 406 | Peptic Ulcer Perforation | 2.8% |
| 407 | Gastric ulcer | 2.8% |
| 408 | Cecal Diseases | 2.8% |
| 409 | Cholangitis | 2.8% |
| 410 | Cholecystitis | 2.8% |
| 411 | Cholestasis | 2.8% |
| 412 | Colonic Diseases | 2.8% |
| 413 | Common Bile Duct Diseases | 2.8% |
| 414 | Esophageal Stenosis | 2.8% |
| 415 | Hepatitis, Chronic | 2.8% |
| 416 | Ileal Diseases | 2.8% |
| 417 | Intestinal Obstruction | 2.8% |
| 418 | Intestinal Perforation | 2.8% |
| 419 | Jejunal Diseases | 2.8% |
| 420 | Pneumatosis Cystoides Intestinalis | 2.8% |
| 421 | Rectal Diseases | 2.8% |
| 422 | Gastric Dilatation | 2.8% |
| 423 | Liver Failure | 2.8% |
| 424 | Gastric outlet obstruction | 2.8% |
| 425 | Cronkhite-Canada Syndrome | 2.8% |
| 426 | Non-alcoholic Fatty Liver Disease | 2.8% |
| 427 | Chronic active hepatitis | 2.8% |
| 428 | Intestinal Polyposis | 2.8% |
| 429 | Leukemia, Myelomonocytic, Chronic | 2.7% |
| 430 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative | 2.7% |
| 431 | Meningeal Carcinomatosis | 2.7% |
| 432 | Colitis, Ischemic | 2.5% |
| 433 | Esophageal Perforation | 2.5% |
| 434 | Hepatitis, Animal | 2.5% |
| 435 | Hepatitis, Viral, Human | 2.5% |
| 436 | Intestinal Diseases, Parasitic | 2.5% |
| 437 | Deglutition Disorders | 2.4% |
| 438 | Mastocytosis | 2.4% |
| 439 | Sturge-Weber Syndrome | 2.4% |
| 440 | Bronchial Neoplasms | 2.4% |
| 441 | Achlorhydria | 2.4% |
| 442 | Liver Cirrhosis, Experimental | 2.4% |
| 443 | Gastric Antral Vascular Ectasia | 2.4% |
| 444 | Multiple Pulmonary Nodules | 2.4% |
| 445 | Hemangioma, Cavernous | 2.4% |
| 446 | Peptic Ulcer Hemorrhage | 2.4% |
| 447 | Gastroparesis | 2.4% |
| 448 | Leukemia, T-Cell | 2.4% |
| 449 | Leukemia, B-Cell | 2.4% |
| 450 | neurofibroma | 2.4% |
| 451 | Supratentorial Neoplasms | 2.4% |
| 452 | Lymphoma, Follicular | 2.4% |
| 453 | T-Cell Lymphoma | 2.4% |
| 454 | Mantle cell lymphoma | 2.4% |
| 455 | Endometrial Neoplasms | 2.4% |
| 456 | Pheochromocytoma | 2.4% |
| 457 | Alveolar rhabdomyosarcoma | 2.4% |
| 458 | Congenital Hypothyroidism | 2.4% |
| 459 | Adrenal Cortex Diseases | 2.3% |
| 460 | Euthyroid Sick Syndromes | 2.3% |
| 461 | Goiter | 2.3% |
| 462 | Hyperparathyroidism | 2.3% |
| 463 | Hyperthyroidism | 2.3% |
| 464 | Hyperthyroxinemia | 2.3% |
| 465 | Hypogonadism | 2.3% |
| 466 | Hypoparathyroidism | 2.3% |
| 467 | Hypothyroidism | 2.3% |
| 468 | Delayed Puberty | 2.3% |
| 469 | Precocious Puberty | 2.3% |
| 470 | Thyroiditis | 2.3% |
| 471 | Hypogonadotropic hypogonadism | 2.3% |
| 472 | Testotoxicosis | 2.3% |
| 473 | Secondary hypothyroidism | 2.3% |
| 474 | Primary Hyperthyroidism | 2.3% |
| 475 | Primary Hypothyroidism | 2.3% |
| 476 | Carcinoma | 2.3% |
| 477 | Epithelioma | 2.3% |
| 478 | Hepatitis B, Chronic | 2.2% |
| 479 | Hepatitis C, Chronic | 2.2% |
| 480 | Colonic Pseudo-Obstruction | 2.2% |
| 481 | Hypopharyngeal Neoplasms | 2.2% |
| 482 | Pleural Effusion, Malignant | 2.2% |
| 483 | Hypopharyngeal Cancer | 2.2% |
| 484 | Fascioliasis | 2.2% |
| 485 | Echinococcosis, Hepatic | 2.2% |
| 486 | Melena | 2.2% |
| 487 | Parotid Neoplasms | 2.2% |
| 488 | Prostatic Neoplasms, Castration-Resistant | 2.2% |
| 489 | Chemical and Drug Induced Liver Injury, Chronic | 2.2% |
| 490 | Reye Syndrome | 2.2% |
| 491 | Hematemesis | 2.1% |
| 492 | Testicular Diseases | 2.1% |
| 493 | Zellweger Syndrome | 2% |
| 494 | Ovarian Diseases | 2% |
| 495 | Empty Sella Syndrome | 2% |
| 496 | Hyperpituitarism | 2% |
| 497 | Hypopituitarism | 2% |
| 498 | Hypophysitis | 2% |
| 499 | Graves Disease | 2% |
| 500 | fibroma | 1.9% |
| 501 | Fibromatosis | 1.9% |
| 502 | Osteoblastoma | 1.9% |
| 503 | Osteoma | 1.9% |
| 504 | Rhabdomyoma | 1.9% |
| 505 | Chondromatosis | 1.9% |
| 506 | Hemangioblastoma | 1.9% |
| 507 | Lymphoma, Extranodal NK-T-Cell | 1.9% |
| 508 | Variegate Porphyria | 1.9% |
| 509 | Acute intermittent porphyria | 1.9% |
| 510 | Porphyria Cutanea Tarda | 1.9% |
| 511 | Hepatolenticular Degeneration | 1.9% |
| 512 | Cholestasis, Extrahepatic | 1.8% |
| 513 | Biliary Dyskinesia | 1.8% |
| 514 | Cholangitis, Sclerosing | 1.8% |
| 515 | Colonic Diseases, Functional | 1.8% |
| 516 | Esophageal motility disorders | 1.8% |
| 517 | Fecal Incontinence | 1.8% |
| 518 | Fecal Impaction | 1.8% |
| 519 | Intussusception | 1.8% |
| 520 | Mallory-Weiss Syndrome | 1.8% |
| 521 | Megacolon | 1.8% |
| 522 | Pyloric Stenosis | 1.8% |
| 523 | Liver Failure, Acute | 1.8% |
| 524 | Acalculous Cholecystitis | 1.8% |
| 525 | End Stage Liver Disease | 1.8% |
| 526 | Ileus | 1.8% |
| 527 | Meconium ileus | 1.8% |
| 528 | Nasopharyngeal Neoplasms | 1.8% |
| 529 | Gestational Diabetes | 1.8% |
| 530 | Latent Autoimmune Diabetes in Adults | 1.8% |
| 531 | Diabetes Insipidus | 1.8% |
| 532 | Diabetes Mellitus, Experimental | 1.8% |
| 533 | Brain Stem Neoplasms | 1.8% |
| 534 | Mastocytoma | 1.7% |
| 535 | Mastocytosis, Systemic | 1.7% |
| 536 | Leukemia, Myeloid, Chronic-Phase | 1.7% |
| 537 | Paranasal Sinus Neoplasms | 1.7% |
| 538 | Hermaphroditism | 1.6% |
| 539 | Disorders of Sex Development | 1.6% |
| 540 | Hemorrhoids | 1.6% |
| 541 | Autoimmune hepatitis | 1.6% |
| 542 | Pituitary Apoplexy | 1.6% |
| 543 | Afferent Loop Syndrome | 1.6% |
| 544 | Celiac Disease | 1.6% |
| 545 | Short Bowel Syndrome | 1.6% |
| 546 | Sprue, Tropical | 1.6% |
| 547 | Steatorrhea | 1.6% |
| 548 | Rectocele | 1.6% |
| 549 | Sprue | 1.6% |
| 550 | Diverticulitis | 1.6% |
| 551 | Dumping Syndrome | 1.6% |
| 552 | Rectal Prolapse | 1.6% |
| 553 | Tonsillar Neoplasms | 1.6% |
| 554 | Cerebellar Neoplasms | 1.6% |
| 555 | Cell Transformation, Viral | 1.5% |
| 556 | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 1.5% |
| 557 | Leukemia, Large Granular Lymphocytic | 1.5% |
| 558 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1.5% |
| 559 | Lymphoma, T-Cell, Cutaneous | 1.5% |
| 560 | Lymphoma, AIDS-Related | 1.5% |
| 561 | Enteropathy-Associated T-Cell Lymphoma | 1.5% |
| 562 | Primary Effusion Lymphoma | 1.5% |
| 563 | Hepatitis, Viral, Animal | 1.5% |
| 564 | Choroid Plexus Papilloma | 1.5% |
| 565 | Giardiasis | 1.5% |
| 566 | Hepatitis E | 1.5% |
| 567 | Hepatitis B | 1.4% |
| 568 | Hepatitis C | 1.4% |
| 569 | Diverticulum | 1.4% |
| 570 | Hepatitis A | 1.4% |
| 571 | Diverticulosis | 1.4% |
| 572 | Hepatic Encephalopathy | 1.4% |
| 573 | Cushing Syndrome | 1.4% |
| 574 | Hyperaldosteronism | 1.4% |
| 575 | Hyperparathyroidism, Secondary | 1.4% |
| 576 | Hypoaldosteronism | 1.4% |
| 577 | Thyrotoxicosis | 1.4% |
| 578 | Hyperparathyroidism, Primary | 1.4% |
| 579 | Thyroid Hormone Resistance Syndrome | 1.4% |
| 580 | Adenocarcinoma | 1.4% |
| 581 | Massive Hepatic Necrosis | 1.4% |
| 582 | Esophageal Achalasia | 1.4% |
| 583 | Anal Fissure | 1.4% |
| 584 | Intestinal Pseudo-Obstruction | 1.4% |
| 585 | Irritable Bowel Syndrome | 1.4% |
| 586 | Superior Mesenteric Artery Syndrome | 1.4% |
| 587 | Emphysematous Cholecystitis | 1.4% |
| 588 | Neurogenic Bowel | 1.4% |
| 589 | Sphincter of Oddi Dysfunction | 1.4% |
| 590 | Anal Ulcer | 1.4% |
| 591 | Fibromatosis, Aggressive | 1.4% |
| 592 | Fibromatosis, Abdominal | 1.4% |
| 593 | Kallmann Syndrome | 1.3% |
| 594 | Lactose Intolerance | 1.3% |
| 595 | Diabetic Foot | 1.3% |
| 596 | Burkitt Lymphoma | 1.2% |
| 597 | Maxillary Sinus Neoplasms | 1.2% |
| 598 | Klinefelter Syndrome | 1.2% |
| 599 | Addison Disease | 1.2% |
| 600 | Diabetic Angiopathies | 1.2% |
| 601 | Autoimmune thyroiditis | 1.2% |
| 602 | Primary Adrenal Insufficiency | 1.2% |
| 603 | Diabetic Neuropathies | 1.2% |
| 604 | Myxedema | 1.2% |
| 605 | Orchitis | 1.2% |
| 606 | Diabetic Amyotrophy | 1.2% |
| 607 | Diabetic Autonomic Neuropathy | 1.2% |
| 608 | Diabetic Cardiomyopathies | 1.2% |
| 609 | Pruritus Ani | 1.2% |
| 610 | Ovarian Hyperstimulation Syndrome | 1.2% |
| 611 | Hyperprolactinemia | 1.2% |
| 612 | Cryptosporidiosis | 1.1% |
| 613 | Dupuytren Contracture | 1.1% |
| 614 | Gigantism | 1.1% |
| 615 | Diabetic Nephropathy | 1.1% |
| 616 | Acromegaly | 1.1% |
| 617 | Anovulation | 1.1% |
| 618 | Diabetic Ketoacidosis | 1.1% |
| 619 | Urticaria Pigmentosa | 1.1% |
| 620 | Oophoritis | 1.1% |
| 621 | Mycosis Fungoides | 1.1% |
| 622 | Lymphomatoid Papulosis | 1.1% |
| 623 | Plasmablastic lymphoma | 1.1% |
| 624 | Laryngopharyngeal Reflux | 1% |
| 625 | Cryptorchidism | 1% |
| 626 | Gonadal Dysgenesis | 1% |
| 627 | Adrenogenital Syndrome | 1% |
| 628 | Ovotesticular Disorders of Sex Development | 1% |
| 629 | Hyperglycemic Hyperosmolar Nonketotic Coma | 0.9% |
| 630 | Hashimoto Disease | 0.9% |
| 631 | Hyperandrogenism | 0.9% |
| 632 | Sezary Syndrome | 0.9% |
| 633 | Rift Valley Fever | 0.8% |
| 634 | CREST Syndrome | 0.8% |
| 635 | Diabetic Retinopathy | 0.7% |
| 636 | Turner Syndrome | 0.7% |
| 637 | Waterhouse-Friderichsen Syndrome | 0.6% |
| 638 | Radicular Cyst | 0.6% |
| 639 | Renal Osteodystrophy | 0.5% |
| 640 | Renal rickets | 0.5% |
| 641 | Adrenoleukodystrophy | 0.4% |